While IGF-1 is clinically approved to be used in IGF-1 deficiency, most prominently Laron's dwarfism (458), other clinical trials with encouraging results (496, 497, 498, 499, 500, 501) have not progressed to clinical application. Here, IGF1 is linked to Laron syndrome.